- Home
- ADVM vs MVST Comparison
ADVM vs MVST Comparison
Compare ADVM & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- MVST
- Stock Information
- Founded
- ADVM 2006
- MVST 2006
- Country
- ADVM United States
- MVST United States
- Employees
- ADVM N/A
- MVST N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- ADVM Health Care
- MVST Miscellaneous
- Exchange
- ADVM Nasdaq
- MVST Nasdaq
- Market Cap
- ADVM 119.6M
- MVST 182.8M
- IPO Year
- ADVM 2014
- MVST N/A
- Fundamental
- Price
- ADVM $4.25
- MVST $2.05
- Analyst Decision
- ADVM Strong Buy
- MVST Buy
- Analyst Count
- ADVM 6
- MVST 3
- Target Price
- ADVM $27.83
- MVST $3.33
- AVG Volume (30 Days)
- ADVM 217.5K
- MVST 20.3M
- Earning Date
- ADVM 11-04-2024
- MVST 11-12-2024
- Dividend Yield
- ADVM N/A
- MVST N/A
- EPS Growth
- ADVM N/A
- MVST N/A
- EPS
- ADVM N/A
- MVST N/A
- Revenue
- ADVM $1,000,000.00
- MVST $370,989,000.00
- Revenue This Year
- ADVM N/A
- MVST $19.19
- Revenue Next Year
- ADVM $1,342.84
- MVST $29.35
- P/E Ratio
- ADVM N/A
- MVST N/A
- Revenue Growth
- ADVM N/A
- MVST 39.03
- 52 Week Low
- ADVM $4.01
- MVST $0.15
- 52 Week High
- ADVM $29.70
- MVST $2.87
- Technical
- Relative Strength Index (RSI)
- ADVM 29.33
- MVST 55.05
- Support Level
- ADVM $4.42
- MVST $1.91
- Resistance Level
- ADVM $5.11
- MVST $2.87
- Average True Range (ATR)
- ADVM 0.30
- MVST 0.44
- MACD
- ADVM 0.01
- MVST -0.06
- Stochastic Oscillator
- ADVM 21.05
- MVST 35.69
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.